Julie C. Lively - Concepedia

Author

Julie C. Lively

Harvard University

Also Known As

J.C. LIVELY, Julie C Lively, Julie C. Lively, Julie Lively

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Harvard University Beth Israel Deaconess Medical Center University of California, San Francisco Howard Hughes Medical Institute Harvard University Press

About

Julie C. Lively is an author at Harvard University specializing in cell biology, medicine, and angiogenesis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.9K
2	Cell Biology	6	6	1.9K
3	Health Sciences	1	1	152
4	Cellular Physiology	1	1	550
5	Hepatology	1	1	130

Julie C. Lively

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins Louise E. Reynolds, Lorenza Wyder, Julie C. Lively, Nature Medicine AngiogenesisEnhanced Pathological AngiogenesisImmunologyCell-matrix Interactionβ3 Integrin	2002	608
Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin Yuki Hamano, Michael Zeisberg, Hikaru Sugimoto, Cancer Cell AngiogenesisSuppress AngiogenesisMedicineImmunologyCell-matrix Interaction	2003	550
Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins Akulapalli Sudhakar, Hikaru Sugimoto, Changqing Yang, Proceedings of the National Academy of Sciences	2003	480
Tumstatin, an Endothelial Cell-Specific Inhibitor of Protein Synthesis Yohei Maeshima, Akulapalli Sudhakar, Julie C. Lively, Science AngiogenesisSignal TransductionFocal Adhesion KinaseSignaling PathwayReceptor Tyrosine Kinase	2002	436
Elevated Flk1 (Vascular Endothelial Growth Factor Receptor 2) Signaling Mediates Enhanced Angiogenesis in β3-Integrin–Deficient Mice Andrew R. Reynolds, Louise E. Reynolds, Tobi Nagel, Cancer Research β3-Integrin–deficient MiceTumor BiologyTumor AngiogenesisAngiogenesisReceptor Tyrosine Kinase	2004	152
Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Changqing Yang, Michael Zeisberg, Julie C. Lively, PubMed Biological MicroenvironmentsPathologyTumor BiologyHcc Cell MigrationHepatobiliary Tumor	2003	130
Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner Liang Xie, Michael B. Duncan, Jessica Pahler, Proceedings of the National Academy of Sciences ImmunologyPathologyCancer BiologyTumor BiologyTumor Angiogenesis	2011	53

Page 1